DAPSONE 6% / NIACINAMIDE 2% / TRETINOIN 0.025%- dapsone 6% / niacinamide 2% / tretinoin 0.025% gel 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

DAPSONE 6% / NIACINAMIDE 2% / TRETINOIN 0.025%

Directions for Use

wr

Sincerus Flroida, LLC, adverse reactions

w

Active, Inactive

dgv

NDC 72934-1062-2. DAPSONE USP 6%/ NIACINAMIDE USP 2% / TRETINOIN USP 0.025%. Gel30gm.

zsfd

DAPSONE 6% / NIACINAMIDE 2% / TRETINOIN 0.025% 
dapsone 6% / niacinamide 2% / tretinoin 0.025% gel
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-1062
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE2 g  in 100 g
DAPSONE (UNII: 8W5C518302) (DAPSONE - UNII:8W5C518302) DAPSONE6 g  in 100 g
TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R) TRETINOIN0.025 g  in 100 g
Product Characteristics
ColoryellowScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-1062-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/04/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/04/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-1062)

Revised: 5/2019
Document Id: 88011b04-0618-48ad-e053-2a95a90aa384
Set id: 88011b04-0617-48ad-e053-2a95a90aa384
Version: 1
Effective Time: 20190503
 
Sincerus Florida, LLC